Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0QCKOE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
OX-003
|
|||||
| Synonyms |
OX 003; OX003
Click to Show/Hide
|
|||||
| Organization |
Oxford BioTherapeutics Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 5 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Clinical candidate
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
Ovarian cancer [ICD11:2C73]
Clinical candidate
Skin cancer [ICD11:2C30-2C37]
Clinical candidate
Small cell lung cancer [ICD11:2C25]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Programmed cell death 1 ligand 1 (CD274)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.